Annual EBITDA
$29.05B$4.04B+16.16%
Summary
- Current Value
- As of today, ABBV annual EBITDA is $29.05B, up +16.16% on
- Historical Performance
- ABBV annual EBITDA is down -6.49% over the past 3 years, up +31.45% over the past 5 years
- All-Time High Comparison
- ABBV annual EBITDA is currently -6.49% below its historical high of $31.07B set on
- 3-Year Low Comparison
- ABBV annual EBITDA is +16.16% above its 3-year low of $25.01B reached on
- Sector Comparison
- ABBV annual EBITDA is higher than 99.74% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $29.05B | +16.2% | -6.5% | +31.4% | +358.2% | |
| Quarterly EBITDA | $7.68B | +13.3% | -6.9% | +16.7% | +526.1% | |
| TTM EBITDA | $28.27B | +13.2% | -8.7% | +34.0% | +2205.9% | |
| Price | $225.09 | +6.1% | +50.4% | +108.0% | – | |
| PE Ratio | 95.32 | +7.5% | +322.1% | +152.2% | – | |
| Annual Revenue | $61.16B | +8.6% | +5.3% | +33.5% | +291.1% | |
| Annual EPS | $2.36 | -1.2% | -64.4% | -13.3% | -10.7% | |
| Annual EBIT | $21.21B | +27.6% | -6.1% | +35.7% | +311.4% | |
| Annual Net Income | $4.19B | -1.3% | -64.4% | -8.1% | +0.4% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $31.07B | N/A | -6.5% |
| 5Y | $31.07B | -6.5% | |
| All | $31.07B | -6.5% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $25.01B | +16.2% | |
| 5Y | $22.10B | N/A | +31.4% |
| All | $5.84B | +397.4% |
EBITDA History
FAQ
What is the current annual EBITDA of ABBV?
As of today, ABBV annual EBITDA is $29.05B
What is 1-year change in ABBV annual EBITDA?
ABBV annual EBITDA is up +16.16% year-over-year
What is 3-year change in ABBV annual EBITDA?
ABBV annual EBITDA is down -6.49% over the past 3 years
How far is ABBV annual EBITDA from its all-time high?
ABBV annual EBITDA is currently -6.49% below its historical high of $31.07B set on December 31, 2022
How does ABBV annual EBITDA rank versus sector peers?
ABBV annual EBITDA is higher than 99.74% of companies in Healthcare sector
When is ABBV next annual earnings release?
As of today, the next annual earnings release for ABBV has not been scheduled
Quarterly EBITDA
$7.68B$1.00B+15.05%
Summary
- Current Value
- As of today, ABBV quarterly EBITDA is $7.68B, up +15.05% on
- Historical Performance
- ABBV quarterly EBITDA is up +13.28% year-over-year, down -6.90% over the past 3 years
- All-Time High Comparison
- ABBV quarterly EBITDA is currently -6.90% below its historical high of $8.24B set on
- 3-Year Low Comparison
- ABBV quarterly EBITDA is +51.59% above its 3-year low of $5.06B reached on
- Sector Comparison
- ABBV quarterly EBITDA is higher than 99.82% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $7.68B | +15.1% | +13.3% | -6.9% | +16.7% | |
| Annual EBITDA | $29.05B | – | +16.2% | -6.5% | +31.4% | |
| TTM EBITDA | $28.27B | +3.3% | +13.2% | -8.7% | +34.0% | |
| Price | $225.09 | +0.8% | +6.1% | +50.4% | +108.0% | |
| PE Ratio | 95.32 | -43.4% | +7.5% | +322.1% | +152.2% | |
| Quarterly Revenue | $16.62B | +5.3% | +10.0% | +9.9% | +19.9% | |
| Quarterly EPS | $1.02 | +925.2% | +5724.3% | -26.8% | +8908.9% | |
| Quarterly EBIT | $5.81B | +26.9% | +24.1% | -4.6% | +28.8% | |
| Quarterly Net Income | $1.81B | +914.0% | +5569.7% | -27.0% | +8104.6% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $7.89B | -2.7% | |
| 3Y | $8.24B | N/A | -6.9% |
| 5Y | $8.24B | -6.9% | |
| All | $8.24B | -6.9% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $6.04B | +27.1% | |
| 3Y | $5.06B | +51.6% | |
| 5Y | $5.06B | +51.6% | |
| All | $381.85M | +1910.0% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ABBV?
As of today, ABBV quarterly EBITDA is $7.68B
What is ABBV quarterly EBITDA most recent change?
ABBV quarterly EBITDA was up +15.05% on December 31, 2025
What is 1-year change in ABBV quarterly EBITDA?
ABBV quarterly EBITDA is up +13.28% year-over-year
How far is ABBV quarterly EBITDA from its all-time high?
ABBV quarterly EBITDA is currently -6.90% below its historical high of $8.24B set on December 31, 2022
How does ABBV quarterly EBITDA rank versus sector peers?
ABBV quarterly EBITDA is higher than 99.82% of companies in Healthcare sector
When is ABBV next earnings release?
The next earnings release for ABBV is on
TTM EBITDA
$28.27B$900.00M+3.29%
Summary
- Current Value
- As of today, ABBV TTM EBITDA is $28.27B, up +3.29% on
- Historical Performance
- ABBV TTM EBITDA is up +13.21% year-over-year, down -8.65% over the past 3 years
- All-Time High Comparison
- ABBV TTM EBITDA is currently -11.02% below its historical high of $31.77B set on
- 3-Year Low Comparison
- ABBV TTM EBITDA is +13.21% above its 3-year low of $24.97B reached on
- Sector Comparison
- ABBV TTM EBITDA is higher than 99.73% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $28.27B | +3.3% | +13.2% | -8.7% | +34.0% | |
| Annual EBITDA | $29.05B | – | +16.2% | -6.5% | +31.4% | |
| Quarterly EBITDA | $7.68B | +15.1% | +13.3% | -6.9% | +16.7% | |
| Price | $225.09 | +0.8% | +6.1% | +50.4% | +108.0% | |
| PE Ratio | 95.32 | -43.4% | +7.5% | +322.1% | +152.2% | |
| TTM Revenue | $61.16B | +2.5% | +8.6% | +5.3% | +33.5% | |
| TTM EPS | $2.36 | +78.2% | -1.3% | -64.4% | -17.5% | |
| TTM EBIT | $20.19B | +5.9% | +21.4% | -10.5% | +37.8% | |
| TTM Net Income | $4.19B | +78.0% | -1.3% | -64.5% | -8.0% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $28.27B | at high | |
| 3Y | $31.77B | -11.0% | |
| 5Y | $31.77B | -11.0% | |
| All | $31.77B | -11.0% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $24.97B | N/A | +13.2% |
| 3Y | $24.97B | +13.2% | |
| 5Y | $21.10B | N/A | +34.0% |
| All | $1.23B | +2205.9% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ABBV?
As of today, ABBV TTM EBITDA is $28.27B
What is ABBV TTM EBITDA most recent change?
ABBV TTM EBITDA was up +3.29% on December 31, 2025
What is 1-year change in ABBV TTM EBITDA?
ABBV TTM EBITDA is up +13.21% year-over-year
How far is ABBV TTM EBITDA from its all-time high?
ABBV TTM EBITDA is currently -11.02% below its historical high of $31.77B set on March 31, 2023
How does ABBV TTM EBITDA rank versus sector peers?
ABBV TTM EBITDA is higher than 99.73% of companies in Healthcare sector
When is ABBV next earnings release?
The next earnings release for ABBV is on
EBITDA Formula
Data Sources & References
- ABBV Official Website www.abbvie.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm
- ABBV Profile on Yahoo Finance finance.yahoo.com/quote/ABBV
- ABBV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/abbv